Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 8-K call announcement, 10-K stay in one workspace.
GLUE
$10.17
+3.04%
GLUE
· Monte Rosa Therapeutics, Inc.
$10.17
+0.30 (+3.04%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$870.20M
Shares
85.31M
Volume · Oct 7
2.08M
Avg daily vol (3M)
1.32M
All webcasts
Earnings call · FY2025 Q4
Monte Rosa Therapeutics, Inc. (GLUE) Q4 2025 Earnings Call
Research coverage
4 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$2.78M
-95.4% YoY
Net income · derived Q4
-$46.11M
-443.1% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Company presentation
Slides
10 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Mar 17, 2026 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 17, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Jan 7, 2026 · complete as-filed document